Table 3.
Expression of p27Kip1, MIB1, and p53 in 10 Cases of Blastic Variant of MCL
Case | Diagnosis | p27* | MiB1 | p53 |
---|---|---|---|---|
1 | MCL-blastic | − | 83% | 20% |
2 | MCL-blastic | − | 80% | 20% |
3 | MCL-blastic | + | 70% | >80% |
4 | MCL-blastic | ++ | 100% | 20% |
5 | MCL-blastic | + | 50% | >80% |
6 | MCL-blastic | + | 95% | <5% |
7 | MCL-blastic | + | 76% | 0%† |
8 | MCL-blastic | + | 32% | 50% |
9 | MCL-blastic | + | 50% | >80% |
10 | MCL-blastic | + | 48% | 0%‡ |
*+, most tumor cells faintly positive and less intense than T lymphocytes; ++, most tumor cells positive with equal intensity as T lymphocytes.
†In this case a homozygous deletion of p16 was detected by Southern blot.
‡In this case a hemizygous deletion of p16 was detected by cytogenetic analysis:del (9) (p12).